GlassScriptPhysician profile
Wilfredo Crespo-Velez
NPI 1952408585
$4,041.75
in general payments reported to CMS, 2019-2025
14 companies · $398 in 2025
The $398 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $633 · 2020: $986 · 2021: $1,439 · 2022: $236 · 2023: $142 · 2024: $207 · 2025: $398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $747.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $1,188.99 | 2020-2025 | Acrobat-I Stabilizer, Vasoview Hemopro 2, Acrobat-I Stabilizer |
| Silk Road Medical, INC. | $1,165.04 | 2021 | |
| Covidien LP | $548.49 | 2019 | |
| Medtronic Vascular, INC. | $304.01 | 2020 | |
| Atricure, INC. | $189.52 | 2022-2025 | Atricure Cryoice Cryoablation System (Cryo2), Atricure Cryoice Cryosphere Cryoablation System, Atriclip Laa Exclusion System |
| Abiomed | $157.42 | 2022 | |
| Lemaitre Vascular, INC. | $123.97 | 2022-2023 | Artegraft Vascular Graft, Pruitt F3 Carotid Shunt |
| Esperion Therapeutics, INC. | $104.81 | 2021 | |
| Bolton Medical INC | $95.29 | 2024 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Bard Access Systems, INC. | $84.66 | 2019 | |
| Boston Scientific Corporation | $22.64 | 2023 | Imager II |
| Edwards Lifesciences Corporation | $21.05 | 2023 | Konect Resilia |
| Abbott Laboratories | $20.45 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $15.41 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wilfredo Crespo-Velez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.